- Home
- BEEM vs ESLA Comparison
BEEM vs ESLA Comparison
Compare BEEM & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BEEM | ESLA |
|---|---|---|
| Founded | 2006 | 2021 |
| Country | United States | United States |
| Employees | 220 | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.3M | 45.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BEEM | ESLA |
|---|---|---|
| Price | $1.18 | $0.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $3.50 | ★ $8.00 |
| AVG Volume (30 Days) | ★ 1.6M | 36.7K |
| Earning Date | 04-09-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $40.48 | N/A |
| Revenue Next Year | $32.17 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.10 | $0.78 |
| 52 Week High | $4.04 | $3.15 |
Technical Indicators
Market Signals| Indicator | BEEM | ESLA |
|---|---|---|
| Relative Strength Index (RSI) | 37.71 | 36.88 |
| Support Level | $1.10 | N/A |
| Resistance Level | $1.66 | $1.31 |
| Average True Range (ATR) | 0.12 | 0.09 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 23.60 | 19.37 |
Price Performance
Historical ComparisonAbout BEEM Beam Global
Beam Global is a clean-technology innovation company. It develop, design, engineer, manufacture, and sell high-quality, renewably energized infrastructure products for electric vehicle ( EV ) charging, infrastructure for Smart Cities (the interconnected physical and digital elements within a city that utilize technology to enhance efficiency, sustainability, and quality of life for residents), energy security and disaster preparedness and energy-dense battery solutions in safe, compact and form-factors. Additionally, the company manufactures structures with electronic integration such as streetlighting, cell towers and energy infrastructure products as well as power electronics including invertors, charge controllers, power supplies and LED lighting.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.